These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
928 related articles for article (PubMed ID: 8995542)
1. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma. Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542 [TBL] [Abstract][Full Text] [Related]
2. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines. Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928 [TBL] [Abstract][Full Text] [Related]
3. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252 [TBL] [Abstract][Full Text] [Related]
4. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes. Tan TM; Ting RC Cancer Res; 1995 Oct; 55(20):4599-605. PubMed ID: 7553636 [TBL] [Abstract][Full Text] [Related]
6. Combination anti-gene therapy targeting c-myc and p53 in ovarian cancer cell lines. Janicek MF; Sevin BU; Nguyen HN; Averette HE Gynecol Oncol; 1995 Oct; 59(1):87-92. PubMed ID: 7557622 [TBL] [Abstract][Full Text] [Related]
7. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses. Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886 [TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer. Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054 [TBL] [Abstract][Full Text] [Related]
9. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Putral LN; Bywater MJ; Gu W; Saunders NA; Gabrielli BG; Leggatt GR; McMillan NA Mol Pharmacol; 2005 Nov; 68(5):1311-9. PubMed ID: 16120770 [TBL] [Abstract][Full Text] [Related]
10. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502 [TBL] [Abstract][Full Text] [Related]
11. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer. Jonson AL; Rogers LM; Ramakrishnan S; Downs LS Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502 [TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells. Hamada K; Sakaue M; Alemany R; Zhang WW; Horio Y; Roth JA; Mitchell MF Gynecol Oncol; 1996 Nov; 63(2):219-27. PubMed ID: 8910631 [TBL] [Abstract][Full Text] [Related]
13. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines. Steele C; Cowsert LM; Shillitoe EJ Cancer Res; 1993 May; 53(10 Suppl):2330-7. PubMed ID: 7683572 [TBL] [Abstract][Full Text] [Related]
14. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo. Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers. Mathur RS; Mathur SP Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460 [TBL] [Abstract][Full Text] [Related]
16. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells. Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212 [TBL] [Abstract][Full Text] [Related]
17. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer. Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269 [TBL] [Abstract][Full Text] [Related]
18. Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects. Wang-Johanning F; Gillespie GY; Grim J; Rancourt C; Alvarez RD; Siegal GP; Curiel DT Cancer Res; 1998 May; 58(9):1893-900. PubMed ID: 9581830 [TBL] [Abstract][Full Text] [Related]
19. Adenoviral p53 effects and cell-specific E7 protein-protein interactions of human cervical cancer cells. Choi JW; Ahn WS; Bae SM; Lee DB; Kim YW Biosens Bioelectron; 2005 May; 20(11):2236-43. PubMed ID: 15797321 [TBL] [Abstract][Full Text] [Related]
20. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis. Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]